108 related articles for article (PubMed ID: 3979587)
21. Prolactin levels and bromocriptine treatment of short luteal phase.
Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
[TBL] [Abstract][Full Text] [Related]
22. [Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
Polishuk WZ; Yarkoni S; Ben-David M; Spitz J
Harefuah; 1975 Dec; 89(11):500-3. PubMed ID: 1205386
[No Abstract] [Full Text] [Related]
23. Prolactin and deficient luteal function.
del Pozo E; Wyss H; Tollis G; Alcañiz J; Campana A; Naftolin F
Obstet Gynecol; 1979 Mar; 53(3):282-6. PubMed ID: 424097
[TBL] [Abstract][Full Text] [Related]
24. Premenstrual tension and functional infertility. Aetiology and treatment.
Benedek-Jaszmann LJ; Hearn-Sturtevant MD
Lancet; 1976 May; 1(7969):1095-8. PubMed ID: 57506
[TBL] [Abstract][Full Text] [Related]
25. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
[TBL] [Abstract][Full Text] [Related]
26. Serum prolactin and bromocriptine treatment in female infertility.
Selander K; Saarikoski S; Pystynen P
Reproduccion; 1981; 5(3):135-40. PubMed ID: 7286377
[No Abstract] [Full Text] [Related]
27. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
Motazedian S; Babakhani L; Fereshtehnejad SM; Mojthahedi K
Indian J Med Res; 2010 May; 131():670-4. PubMed ID: 20516539
[TBL] [Abstract][Full Text] [Related]
28. Hyperprolactinemia. Long-term effects of bromocriptine.
Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
[TBL] [Abstract][Full Text] [Related]
29. [Our experience in treating women with pathologic functional hyperprolactinemia and normal blood prolactin levels with bromocriptine].
Markovski N; Ivanov S; Trepechev S; Spasiov S; Zhekova V
Akush Ginekol (Sofiia); 1983; 22(6):417-22. PubMed ID: 6673607
[No Abstract] [Full Text] [Related]
30. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
Eftekhari N; Mohammadalizadeh S
Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
[TBL] [Abstract][Full Text] [Related]
31. [Hyperprolactinemia as a cause of sterility and its treatment with bromoergocryptine].
Pakhomova IA; Manuilova IA; Sotnikova EI; Sharipova MSh
Akush Ginekol (Mosk); 1980 Oct; (10):57-8. PubMed ID: 7446862
[No Abstract] [Full Text] [Related]
32. Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
Dash RJ; Ajmani AK; Sialy R
Horm Metab Res; 1994 Mar; 26(3):164. PubMed ID: 8005568
[No Abstract] [Full Text] [Related]
33. Vaginal bromocriptine--clinical and biochemical effects.
Ginsburg J; Hardiman P; Thomas M
Gynecol Endocrinol; 1992 Jun; 6(2):119-26. PubMed ID: 1502929
[TBL] [Abstract][Full Text] [Related]
34. The effects of combined bromocriptine and Bu-shen-zhu-yun decoction on serum hormones, anxiety, and pregnancy in hyperprolactinemic infertility patients.
Feng H; Zhong Q; Zhou H; Jiang X; Ding Y
Ann Palliat Med; 2021 Dec; 10(12):12230-12243. PubMed ID: 35016475
[TBL] [Abstract][Full Text] [Related]
35. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
36. [Carbohydrate metabolism in normo- and hyperprolactinemic sterility patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
Alexander H; Ulrich FE; Herter U
Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6211038
[No Abstract] [Full Text] [Related]
37. [Sterility in hyperprolactinemic amenorrhea].
Tscherne G; Urdl W
Zentralbl Gynakol; 1983; 105(8):478-81. PubMed ID: 6868876
[TBL] [Abstract][Full Text] [Related]
38. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
[TBL] [Abstract][Full Text] [Related]
39. Transient hyperprolactinemia: a correctable cause of idiopathic female infertility.
Ben-David M; Schenker JG
J Clin Endocrinol Metab; 1983 Aug; 57(2):442-4. PubMed ID: 6863485
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women.
Lin KC; Okamura H; Koshida M; Mori T
Fertil Steril; 1986 Nov; 46(5):846-51. PubMed ID: 3096783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
